UBS Group »

Axsome Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.2M 40k 80.00
2023-09-30 $2.3M 33k 69.89
2023-06-30 $1.0M 15k 71.86
2023-03-31 $1.0M 16k 61.68
2022-12-31 $1.0M 13k 77.13
2022-09-30 $818k 18k 44.68
2022-06-30 $551k 14k 38.32
2022-03-31 $678k 16k 41.36
2021-12-31 $114k 3.0k 37.63
2021-09-30 $308k 9.3k 32.98
2021-06-30 $754k 11k 67.45
2021-03-31 $535k 9.4k 56.67
2020-12-31 $677k 8.9k 75.95
2020-09-30 $959k 14k 71.28
2020-06-30 $1.4M 17k 82.32
2020-03-31 $1.2M 21k 58.85
2019-12-31 $4.6M 44k 103.44
2019-09-30 $926k 46k 20.25
2019-06-30 $86k 3.4k 25.63
2019-03-31 $26k 1.8k 14.17
2018-06-30 $998 279 3.58
2017-09-30 $1.0k 240 4.17
2017-06-30 $8.0k 1.4k 5.79
2017-03-31 $1.0k 269 3.72
2016-12-31 $12k 1.8k 6.86
2016-06-30 $7.0k 937 7.47
2016-03-31 $103k 12k 8.62